ARDS - Aridis Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
3,435
2,757
860
2,269
Cost of Revenue
-
-
0
1,927
Gross Profit
-
-
860
342
Operating Expenses
Research Development
26,260
23,000
17,438
6,261
Selling General and Administrative
5,375
3,874
3,160
1,965
Total Operating Expenses
31,635
26,874
20,598
8,226
Operating Income or Loss
-28,200
-24,117
-19,738
-7,884
Interest Expense
-
420
-
366
Total Other Income/Expenses Net
-2,057
1,592
-5,152
-172
Income Before Tax
-29,794
-22,105
-24,656
-8,422
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-29,794
-22,105
-24,656
-8,422
Net Income
-29,794
-22,105
-24,656
-8,422
Net Income available to common shareholders
-29,799
-23,462
-27,449
-8,887
Reported EPS
Basic
-
-7.02
-3.48
-1.13
Diluted
-
-7.02
-3.48
-1.13
Weighted average shares outstanding
Basic
-
3,147
7,890
7,890
Diluted
-
3,147
7,890
7,890
EBITDA
-
-24,117
-19,676
-7,861